- Home
- ORIC vs DGICA Comparison
ORIC vs DGICA Comparison
Compare ORIC & DGICA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIC
- DGICA
- Stock Information
- Founded
- ORIC 2014
- DGICA 1986
- Country
- ORIC United States
- DGICA United States
- Employees
- ORIC N/A
- DGICA N/A
- Industry
- ORIC Biotechnology: Pharmaceutical Preparations
- DGICA Property-Casualty Insurers
- Sector
- ORIC Health Care
- DGICA Finance
- Exchange
- ORIC Nasdaq
- DGICA Nasdaq
- Market Cap
- ORIC 545.5M
- DGICA 646.1M
- IPO Year
- ORIC 2020
- DGICA N/A
- Fundamental
- Price
- ORIC $5.61
- DGICA $19.63
- Analyst Decision
- ORIC Strong Buy
- DGICA
- Analyst Count
- ORIC 9
- DGICA 0
- Target Price
- ORIC $18.43
- DGICA N/A
- AVG Volume (30 Days)
- ORIC 672.2K
- DGICA 117.7K
- Earning Date
- ORIC 05-05-2025
- DGICA 04-24-2025
- Dividend Yield
- ORIC N/A
- DGICA 3.49%
- EPS Growth
- ORIC N/A
- DGICA 1026.10
- EPS
- ORIC N/A
- DGICA 1.50
- Revenue
- ORIC N/A
- DGICA $989,605,050.00
- Revenue This Year
- ORIC N/A
- DGICA $4.59
- Revenue Next Year
- ORIC N/A
- DGICA $4.06
- P/E Ratio
- ORIC N/A
- DGICA $13.14
- Revenue Growth
- ORIC N/A
- DGICA 6.71
- 52 Week Low
- ORIC $5.53
- DGICA $12.26
- 52 Week High
- ORIC $14.67
- DGICA $19.79
- Technical
- Relative Strength Index (RSI)
- ORIC 30.76
- DGICA 80.38
- Support Level
- ORIC $5.78
- DGICA $18.09
- Resistance Level
- ORIC $8.11
- DGICA $18.50
- Average True Range (ATR)
- ORIC 0.52
- DGICA 0.44
- MACD
- ORIC -0.13
- DGICA 0.04
- Stochastic Oscillator
- ORIC 1.59
- DGICA 93.10
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About DGICA Donegal Group Inc.
Donegal Group Inc is an insurance holding company that offers businesses and individuals personal and commercial lines of property and casualty insurance. The company's reportable segments are its Investment function, Personal lines of insurance, and Commercial lines of insurance. Personal lines products consist mainly of homeowners and private passenger automobile policies. The Commercial lines products of its insurance subsidiaries consist mainly of commercial automobile, commercial multi-peril, and workers' compensation policies. The group mainly operates in the United States.